The sentencing of Sarah Khalifa and 11 others underscores the severity of Egypt's anti-drug laws and the exposure of public figures to capital punishment.

GlobalData’s April CPMI shows resilience masking pre-execution caution, with conflict risk surfacing unevenly by country and sector.

Reuters says the AI company will start marketing in mid-October, putting its listing in a politically charged window.

The healthcare giant is doubling down on oncology, betting that targeted therapies and data will reshape how cancer drugs reach patients.

Authors who won a landmark AI copyright settlement are finding their own publishers filed competing claims for the same money.

The family's public grief collides with a flood of AI-generated content, while the estate pivots to a two-city festival to control the narrative.

Eurometal warns Brussels must act now or watch 300,000 manufacturing jobs vanish in the rest of 2026 as Chinese components flood the bloc.

The Ministry of Finance is deploying 360 billion yuan across the country's largest state-owned financial institutions, a rare direct intervention that reshapes the risk picture for China watchers.

Washington blacklisted Inspur for military ties, but its subsidiary kept shipping Nvidia's top AI chips to China's leading firms - exposing a compliance gap with huge stakes.

The EV maker will debut its autonomous robotaxi in Beijing and Shanghai mid-September, hoping its tech wow-factor reignites demand in its second-largest market.

Senator Wyden and Rep. Harrigan ask the DoD Inspector General to investigate why commercial location data from military facilities remains available despite new ad-ID controls.

Hui Ka-yan's sentence closes a debt saga, but unease persists for private developers as state-owned rivals circle.